October Monthly Edition 2025

Vobis, LLC Shuns the Off-the-Shelf Catalog, Engineering Custom Thermal Systems on Three-to-Four-Month Timelines

thesiliconreview-brian-bolluyt-founder-vobis-llc copy_2026-10-26_14-36-04.webp

Capital equipment purchasing in chemical processing tends to follow a predictable script: the buyer studies a catalog, selects the nearest available configuration, and then spends months negotiating modifications. Brian M. Bolluyt founded Vobis, LLC specifically to break that script. After more than a dozen years working for dedicated manufacturers of evaporation, crystallization and drying technologies, he built a company on a deliberate refusal no off-the-shelf solutions, only systems integrated around a specific client's process, budget and delivery deadline.

Headquartered in Easton, Pennsylvania, Vobis operates across two technology arenas that rarely share a supplier. The first is evaporation and crystallization: falling film, forced circulation, rising film, MVR, TVR, wiped film, short path and molecular distillation, plus evaporative, cooling and draft tube baffle crystallizer designs. The second is granulation and microencapsulation, spanning low-pressure extrusion, high-pressure pelleting, spheronization and spray drying. Systems range from pilot scale to production throughputs exceeding 10,000 kilograms per hour.

The operating model depends on strategically located manufacturing shops in the United States and abroad, a structure Bolluyt credits with delivering competitive technical and economic outcomes. Vobis reports systems delivered to Asia, North America, Europe and South America, with designs meeting ASME and CE codes and 3A sanitary standards. The company's stated delivery window under four months is an unusual claim in an industry where lead times frequently stretch past a year.

Where Engineering Judgment Replaces the Catalog

The commercial distinction Vobis draws is between supplying equipment and supplying a fit. Its engineers carry more than a century of combined evaporation and crystallization application experience, and the company's stated practice is to redirect prospective clients elsewhere when its expertise is not relevant. That posture has a revenue consequence: it narrows the addressable market while raising the win rate inside it. Clients arriving with an unusual feed stream lithium salts, isocyanates, omega-3 fatty acids, high-viscosity polymers are precisely the buyers for whom a standard unit will not work. Scope flexibility reinforces the point. Vobis supplies component packages, skid-mounted systems, modular designs or entire facilities, and it also offers fabrication-only capability for clients who arrive with a completed design and need a competent shop to deliver tanks, columns, falling film effects and piping trains.

The Decision to Run Two Technology Programs

Maintaining evaporation and microencapsulation under one roof is an unusual strategic choice, and it creates two distinct revenue engines. The evaporation side serves chemical process, pharmaceutical, biotech, food, dairy, nutraceutical, natural gas, nuclear and environmental industries, with an application list running from glycol recovery and kraft liquor to whey, gelatin, phosphoric acid and desalination. The microencapsulation side serves pharmaceutical, nutraceutical, cosmetic, agricultural and consumer care clients, with contract manufacturing campaigns scaling from grams to hundreds of tons annually.

The logic connecting them is formulation development. Vobis maintains laboratory and pilot testing capability in the United States, Europe and Asia, including HPLC and gas chromatography instrumentation, and uses that capability to convert capital equipment inquiries into validated process designs. A client who begins with a bench trial frequently becomes a toll processing customer, then a system buyer.

Toll Processing as the Bridge between Sale and Scale

Toll processing is where Vobis converts technical credibility into recurring revenue. The company operates production-scale wiped film and short path distillation toll campaigns, handling quantities from 100 grams to multiple rail car volumes, at vacuum levels down to 0.001 mbar and temperatures to 350 degrees Celsius. Applications include omega-3 concentration, isocyanate purification, and monoglyceride processing, solvent removal from herbal extracts and glycerine recovery from crude streams.

The strategic value is timing. A client awaiting capital approval or drug approval can begin commercial production through tolling without committing to equipment. In pharmaceuticals, Vobis manufactures the biobatches required before final approval work that generates revenue, validates the process at scale, and positions the company as the natural equipment supplier once capex is released.

What Custom Engineering Is Worth in a Commodity Market?

Thermal processing equipment is often sold as a commodity differentiated on price and lead time. Vobis's proposition rests on a third variable: whether the system actually fits the feed stream. That argument holds where materials are difficult, specifications are regulated or waste reduction carries financial consequence conditions common across the industries the company serves. With roughly three decades of accumulated application experience, a global shop footprint and a sub-four-month delivery claim, Vobis has built a position that depends less on catalog breadth than on the willingness to say no to the wrong project.

Brian Bolluyt, founder

"We do not offer any 'off the shelf' solutions, rather we consult directly with our clients to provide custom systems comprised of the correct integrated components that will accomplish the intended goal in a cost effective and timely manner."

Client-Speak Magazine Subscribe Newsletter Video
🚀 NOMINATE YOUR COMPANY NOW 🎉 GET 10% OFF 🏆 LIMITED TIME OFFER Nominate Now →